Search results
Results from the WOW.Com Content Network
The McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD) is a 10-question self-report screening tool used to identify individuals who may warrant further evaluation for borderline personality disorder (BPD). The questionnaire asks individuals about the presence of symptoms they experience that are characteristic of BPD.
The Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) is a standardized, diagnostic rating scale designed to measure the severity and changes in the symptoms of borderline personality disorder (BPD) over time. [1] [2] The assessment was developed by Mary Zanarini and her colleagues at McLean Hospital and released in 2003. [3]
Hence, the gender gap observed in antisocial personality disorder and borderline personality disorder, which may share similar underlying pathologies but present different symptoms influenced by gender. In a study examining completed suicides among individuals aged 18 to 35, 30% of the suicides were attributed to people with BPD, with a ...
The Millon Clinical Multiaxial Inventory – Fourth Edition (MCMI-IV) is the most recent edition of the Millon Clinical Multiaxial Inventory.The MCMI is a psychological assessment tool intended to provide information on personality traits and psychopathology, including specific mental disorders outlined in the DSM-5.
This page was last edited on 14 October 2024, at 15:23 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Borderline intellectual functioning, previously called borderline mental retardation (in the ICD-8), [1] is a categorization of intelligence wherein a person has below average cognitive ability (generally an IQ of 70–85), [2] but the deficit is not as severe as intellectual disability (below 70). It is sometimes called below average IQ (BAIQ).
Pilot study of group schema therapy for borderline personality disorder [ edit ] Investigators Joan Farrell, Ida Shaw and Michael Webber at the Indiana University School of Medicine Center for BPD Treatment & Research tested the effectiveness of adding an eight-month, 30-session schema therapy group to treatment-as-usual (TAU) for borderline ...
The UK's National Institute for Health and Clinical Excellence (NICE) in 2009 advises against the use of medication for treating borderline personality disorder, recommending that they only be considered for comorbid conditions. [33]